LCTX
AMEX · Biotechnology
Lineage Cell Therapeutics In
$1.53
+0.02 (+1.32%)
Analyst Consensus
Strong Buy
14
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+2,541.8% upside
Low Target
$29.91
Average Target
$40.42
High Target
$53.83
Current Price
$1.53
Current
$1.53
$1.53
Target
$40.42
$40.42
$29.91
$40.42 avg
$53.83
Scenario Analysis
Bear Case
$29.91
1,854.9%
Low target
Base Case
$40.42
+2,541.8%
Avg target
Bull Case
$53.83
+3,418.3%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$2.09
-26.8% from high
52-Week Low
$0.43
+255.8% from low
Target vs 52W High
$40.42
+1,834.0% vs high
Next Earnings Report
May 12, 2026 · After Market Close
1d
tomorrow
EPS Est: $-0.02
Earnings in 1 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 40 | 75% | $257.58 | +27.8% |
| AMGN | Hold | 44 | 48% | $190.87 | -42.5% |
| GILD | Strong Buy | 39 | 79% | $362.68 | +176.2% |
| VRTX | Strong Buy | 39 | 79% | $438.34 | +2.0% |
| REGN | Strong Buy | 38 | 79% | $76.80 | -89.3% |
| ALNY | Strong Buy | 36 | 75% | $102.31 | -65.3% |
| RVMD | Strong Buy | 27 | 96% | $114.11 | -19.5% |
| INSM | Strong Buy | 28 | 96% | $143.40 | +41.5% |